List of drugs in development for neurodegenerative diseases. Update September 2005 - PubMed (original) (raw)

Comparative Study

doi: 10.1159/000089285.

Affiliations

Comparative Study

List of drugs in development for neurodegenerative diseases. Update September 2005

Myoung-Ok Kwon et al. Neurodegener Dis. 2005.

No abstract available

List of drugs in development for neurodegenerative diseases. Update June 2006.
Kwon MO, Herrling P. Kwon MO, et al. Neurodegener Dis. 2006;3(3):148-86. doi: 10.1159/000094773. Neurodegener Dis. 2006. PMID: 16954701 No abstract available.
List of drugs in development for neurodegenerative diseases. Update June 2007.
Pogacić V, Herrling P. Pogacić V, et al. Neurodegener Dis. 2007;4(6):443-86. doi: 10.1159/000107705. Neurodegener Dis. 2007. PMID: 17934328 No abstract available.
List of drugs in development for neurodegenerative diseases. Update June 2004.
Kwon MO, Fischer F, Matthisson M, Herrling P. Kwon MO, et al. Neurodegener Dis. 2004;1(2-3):113-52. doi: 10.1159/000081242. Neurodegener Dis. 2004. PMID: 16908983 No abstract available.
The emergence of designed multiple ligands for neurodegenerative disorders.
Geldenhuys WJ, Youdim MB, Carroll RT, Van der Schyf CJ. Geldenhuys WJ, et al. Prog Neurobiol. 2011 Sep 1;94(4):347-59. doi: 10.1016/j.pneurobio.2011.04.010. Epub 2011 Apr 22. Prog Neurobiol. 2011. PMID: 21536094 Review.
[The concept of neuroprotective agents as a treatment modulator in the development of brain diseases].
Bordet R, Lestage P, Onteniente B; table ronde no 4 de Giens XXI (2005). Bordet R, et al. Therapie. 2007 Nov-Dec;62(6):463-72. doi: 10.2515/therapie:2007077. Epub 2008 Mar 4. Therapie. 2007. PMID: 18316011 Review. French. No abstract available.

Why do so many drugs for Alzheimer's disease fail in development? Time for new methods and new practices?
Becker RE, Greig NH, Giacobini E. Becker RE, et al. J Alzheimers Dis. 2008 Oct;15(2):303-25. doi: 10.3233/jad-2008-15213. J Alzheimers Dis. 2008. PMID: 18953116 Free PMC article. Review.